scholarly journals Prevalence and Predictors of Patient Nonadherence to Pharmacological Acute Pain Therapy at Home After Day Surgery: A Prospective Cohort Study

Pain Practice ◽  
2017 ◽  
Vol 18 (2) ◽  
pp. 194-204 ◽  
Author(s):  
Björn Stessel ◽  
Maurice Theunissen ◽  
Marco A. Marcus ◽  
Elbert A. Joosten ◽  
Sander M. J. van Kuijk ◽  
...  
Keyword(s):  
Cohort Study ◽  
Prospective Cohort Study ◽  
Acute Pain ◽  
Prospective Cohort ◽  
Pain Therapy ◽  
Day Surgery ◽  
Acute Pain Therapy ◽  
Patient Nonadherence ◽  
At Home

scholarly journals Incidence of home delivery among women living with HIV in Lira, Northern Uganda: a prospective cohort study

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Agnes Napyo Kasede ◽  
Thorkild Tylleskär ◽  
David Mukunya ◽  
Josephine Tumuhamye ◽  
Grace Ndeezi ◽  
...  
Keyword(s):  
Risk Factors ◽  
Cohort Study ◽  
Prospective Cohort Study ◽  
Prospective Cohort ◽  
Home Delivery ◽  
Northern Uganda ◽  
Adjusted Risk ◽  
Women Living With Hiv ◽  
Living With Hiv ◽  
At Home

Abstract Background Home delivery has been associated with mother-to-child transmission of HIV and remains high among HIV-infected women. Predictors for home delivery in the context of HIV have not been fully studied and understood in Northern Uganda. We therefore aimed to find out the incidence and risk factors for home delivery among women living with HIV in Lira, Northern Uganda. Methods This prospective cohort study was conducted between August 2018 and January 2020 in Lira district, Northern Uganda. A total of 505 HIV infected women receiving antenatal care at Lira regional referral hospital were enrolled consecutively and followed up at delivery. We used a structured questionnaire to obtain data on exposures which included: socio-demographic, reproductive-related and HIV-related characteristics. Data was analysed using Stata version 14.0 (StataCorp, College Station, Texas, U.S.A.). We estimated adjusted risk ratios using Poisson regression models to ascertain risk factors for the outcome of interest which was home delivery (which is delivering an infant outside a health facility setting under the supervision of a non-health worker). Results The incidence of home delivery among women living with HIV was 6.9% (95%CI: 4.9–9.5%). Single women were more likely to deliver at home (adjusted risk ratio = 4.27, 95%CI: 1.66–11). Women whose labour started in the night (night time onset of labour ARR = 0.39, 95%CI: 0.18–0.86) and those that were adherent to their ART (ARR = 0.33, 95%CI: 0.13–0.86) were less likely to deliver at home. Conclusion Home delivery remains high among women living with HIV especially those that do not have a partner. We recommend intensified counselling on birth planning and preparedness in the context of HIV and PMTCT especially for women who are: separated, divorced, widowed or never married and those that are not adherent to their ART.

Day surgery versus Outpatient setting for endovenous laser ablation treatment. A prospective cohort study

2018 ◽  
Vol 51 ◽  
pp. 180-183 ◽  
Author(s):  
Gianfranco Varetto ◽  
Lorenzo Gibello ◽  
Edoardo Frola ◽  
Alessandra Trevisan ◽  
Andrea Trucco ◽  
...  
Keyword(s):  
Cohort Study ◽  
Laser Ablation ◽  
Prospective Cohort Study ◽  
Prospective Cohort ◽  
Day Surgery ◽  
Outpatient Setting ◽  
Endovenous Laser Ablation

scholarly journals Cervical ripening at home or in-hospital—prospective cohort study and process evaluation (CHOICE) study: a protocol

BMJ Open ◽  
2021 ◽  
Vol 11 (5) ◽  
pp. e050452
Author(s):  
Sarah Jane Stock ◽  
Amarnath Bhide ◽  
Heather Richardson ◽  
Mairead Black ◽  
Cassandra Yuill ◽  
...  
Keyword(s):  
Cohort Study ◽  
Cost Effectiveness ◽  
Incremental Cost ◽  
Process Evaluation ◽  
Prospective Cohort Study ◽  
Prospective Cohort ◽  
Cost Effectiveness Analysis ◽  
Cervical Ripening ◽  
Effectiveness Analysis ◽  
At Home

IntroductionThe aim of the cervical ripening at home or in-hospital—prospective cohort study and process evaluation (CHOICE) study is to compare home versus in-hospital cervical ripening to determine whether home cervical ripening is safe (for the primary outcome of neonatal unit (NNU) admission), acceptable to women and cost-effective from the perspective of both women and the National Health Service (NHS).Methods and analysisWe will perform a prospective multicentre observational cohort study with an internal pilot phase. We will obtain data from electronic health records from at least 14 maternity units offering only in-hospital cervical ripening and 12 offering dinoprostone home cervical ripening. We will also conduct a cost-effectiveness analysis and a mixed methods study to evaluate processes and women/partner experiences. Our primary sample size is 8533 women with singleton pregnancies undergoing induction of labour (IOL) at 39+0 weeks’ gestation or more. To achieve this and contextualise our findings, we will collect data relating to a cohort of approximately 41 000 women undergoing IOL after 37 weeks. We will use mixed effects logistic regression for the non-inferiority comparison of NNU admission and propensity score matched adjustment to control for treatment indication bias. The economic analysis will be undertaken from the perspective of the NHS and Personal Social Services (PSS) and the pregnant woman. It will include a within-study cost-effectiveness analysis and a lifetime cost–utility analysis to account for any long-term impacts of the cervical ripening strategies. Outcomes will be reported as incremental cost per NNU admission avoided and incremental cost per quality adjusted life year gained.Research ethics approval and disseminationCHOICE has been funded and approved by the National Institute of Healthcare Research Health Technology and Assessment, and the results will be disseminated via publication in peer-reviewed journals.Trial registration numberISRCTN32652461.

Sign in / Sign up

Export Citation Format

Share Document